First Treatment in 30 Years for Rare Disease Safe, Effective 🔗 Access full article via Medscape NeurologySubcutaneous efgartigimod PH20 SC is effective and tolerable for the treatment of CIDP, providing a convenient alternative to intravenous and other older treatments. Medscape Medical News Share:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon